ClinicalTrials.gg
CompletedNCT07700797Updated Jul 17, 2026

Adductor Canal Block With IPACK Versus 4-in-1 Block for Postoperative Analgesia in Knee Surgery

An interventional study of Adductor canal block with IPACK and 4 in 1 block in Knee Surgeries, Total Ankle Arthroplasty and Anterior Cruciate Ligament (ACL) Tear, sponsored by Zagazig University. Completed at 1 site in Egypt. Open to participants aged 21 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-17.

Sponsored by Zagazig University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
21 Years to 64 Years
Sex
All
01

Study summary

This randomized interventional study compares the analgesic efficacy of Adductor Canal Block combined with Infiltration of the Posterior Capsule of the Knee (IPCAK) versus the 4-in-1 block technique in patients undergoing knee surgery. Twenty-four patients were randomly allocated into two equal groups. The primary objective is to compare postoperative pain scores and analgesic requirements. Secondary outcomes include time to first rescue analgesia, total analgesic consumption, motor function preservation, and block-related complications.

Read the detailed description

Effective postoperative pain control following knee surgery is essential for early mobilization, rehabilitation, and patient satisfaction. Several regional anesthesia techniques have been developed to provide analgesia while preserving quadriceps muscle strength. Adductor Canal Block combined with Infiltration of the Posterior Capsule of the Knee (IPCAK) has been proposed as a motor-sparing technique that provides effective anterior and posterior knee analgesia. The 4-in-1 block is another ultrasound-guided regional anesthesia technique designed to provide comprehensive analgesia for knee surgery.

This prospective randomized interventional study enrolled 24 patients undergoing knee surgery. Participants were randomly assigned to receive either Adductor Canal Block with IPCAK or the 4-in-1 block. Postoperative pain scores, time to first rescue analgesia, total analgesic consumption, motor function, patient satisfaction, and complications were evaluated and compared between the two groups

02

Conditions studied

  • Knee Surgeries
  • Total Ankle Arthroplasty
  • Anterior Cruciate Ligament (ACL) Tear
  • Posterior Cruciate Ligament Tear

Browse trials for

Keywords

  • Adductor canal block
  • IPACK
  • 4 in 1 block
  • Knee surgeries
  • Postoperative analgesia
  • Regional anesthesia
  • Ultrasound guided nerve block
03

In context

Lacerations

174 studies on the registry are indexed under Lacerations; 43 are open to participants now.

This study's enrollment of 24 is below the median of 65 across 128 interventional studies indexed under Lacerations.

Browse Lacerations studies →

Lead sponsor

Zagazig University is the lead sponsor of 459 studies on the registry; 77 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1. Patients or caregivers acceptance. 2. Age : 21 - 64 years 3. Sex : both ( males \& females). 4. Physical status: ASA І \& II. 5. 18.5-30 kg/m2. 6. Type of operations : elective surgery. 7. Type of anesthesia: unilateral intrathecal anesthesia. 8. Patients undergoing elective knee surgery under unilateral spinal anesthesia 9. Duration of surgery within 2 hr.

Exclusion criteria

Exclusion Criteria:

  • Known history of allergy to study drug Coagulopathies or taking drugs affecting coagulation.. for peripheral nerve block (PNB) and spinal anesthesia (SA) (coagulation defects, infection at the puncture site), bone degenerative disease and posttraumatic condition of the spine, dementia and severe visual or auditory disorder.

Current severe psychiatric disease, alcoholism or drug dependence. Subjects with history previous knee surgery, osteoarthritis, malformation or tumors (including Baker's cyst), which could alter the normal anatomy of the popliteal fossa

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Adductor canal block+ IPACK

    Patients receive ultrasound-guided Adductor Canal Block combined with Infiltration of the Posterior Capsule of the Knee (IPCAK) for postoperative analgesia after knee surgery

    Procedure: Adductor canal block with IPACK

  • Experimental
    4 in 1 block

    Patients receive ultrasound-guided 4-in-1 block for postoperative analgesia after knee surgery.

    Procedure: 4 in 1 block

Interventions

  • ProcedureAdductor canal block with IPACK

    Ultrasound-guided Adductor Canal Block combined with IPCAK block

  • Procedure4 in 1 block

    Ultrasound-guided 4-in-1 block technique.

06

What researchers measure

Primary outcomes

  1. Postoperative pain intensity measured by Visual Analog Scale (VAS)

    Postoperative pain will be assessed using the Visual Analog Scale (VAS) at rest and during movement at predetermined postoperative time points

    Time frame: 24 hours after surgery

Secondary outcomes

  1. Total opioid consumption

    Total rescue opioid analgesic consumption during the first 24 postoperative hours

    Time frame: First 24 hours after surgery

  2. Time to first rescue analgesia

    Time from completion of surgery to the first request for rescue analgesia

    Time frame: Within 24 hours after surgery

  3. Patient satisfaction with postoperative analgesia

    Patient satisfaction score regarding postoperative pain management

    Time frame: 24 hours after surgery

07

Study locations

1 site
  • Faculty of Medicine, Zagazig University Hospitals
    Zagazig, Sharqia Province 055, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07700797
Lead sponsor
Zagazig University
Responsible party
Sponsor
First posted
Jul 14, 2026
Start date
Jun 22, 2026
Primary completion
Jun 22, 2026
Completion
Jun 22, 2026
Last update
Jul 17, 2026

Study contacts

Abdalla Mohamed Goda, MD
study chair · Faculty of Medicine, Zagazig University
Yasser Mohamed Naser, MD
study director · Faculty of Medicine, Zagazig University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion